NCT05231005View on ClinicalTrials.gov

Fourth BNT162b2 COVID-19 Vaccine Dose

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 27, 2021

Primary Completion Date

June 26, 2024

Study Completion Date

June 26, 2024

Conditions
COVID-19 Pandemic
Interventions
BIOLOGICAL

BNT162b2 vaccine

fourth dose of the BNT162b2 vaccine (30 microgram) adminstered IM

Trial Locations (1)

5265601

Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT05231005 - Fourth BNT162b2 COVID-19 Vaccine Dose | Biotech Hunter | Biotech Hunter